Pediatric Oncology News

Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.

Scott A. Armstrong, MD, PhD, has been named senior vice president for drug discovery and chief research strategy officer at Dana-Farber Cancer Institute, according to a press release.

Individuals with tooth agenesis may be more likely to develop several different cancer types from childhood through young adulthood, according to results published in JAMA Network Open.

Childhood cancer survivors had a significantly higher prevalence of smoking than the general population, contrary to previous research, according to a study published in BMC Cancer.

Adoptive cellular therapies such as chimeric antigen receptor T-cell therapy have transformed the landscape of care for patients with relapsed or refractory hematologic malignancies.

The FDA approved inotuzumab ozogamicin for use in pediatric patients with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia, according to a press release.

The combination of abnormal baseline global longitudinal strain and N-terminal-pro-B-type natriuretic peptide is associated with a more than fourfold risk for subsequent cardiomyopathy among certain childhood cancer survivors.

More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

A COVID-19 diagnosis led to a delay in receiving chemotherapy among younger patients with acute lymphoblastic leukemia or lymphoblastic lymphoma, results from a retrospective analysis published in JAMA Network Open showed.